Search

Your search keyword '"DeSouza, Nandita M."' showing total 575 results
Start Over Author "DeSouza, Nandita M."
575 results on '"DeSouza, Nandita M."'

1. Color-map recommendation for MR relaxometry maps

Author

Fuderer, Miha, Wichtmann, Barbara, Crameri, Fabio, deSouza, Nandita M., Baeßler, Bettina, Gulani, Vikas, Wang, Meiyun, Poot, Dirk, de Boer, Ruud, Cashmore, Matt, de Graaf, Wolter, Keenan, Kathryn E., Ma, Dan, Pirkl, Carolin, Sollmann, Nico, Weingärtner, Sebastian, Mandija, Stefano, and Golay, Xavier

Subjects
Physics - Medical Physics
Abstract

Purpose: To harmonize the use of color for MR relaxometry maps and therefore recommend the use of specific color-maps for representing T1 and T2 maps. Methods: Perceptually linearized color-maps were chosen to have similar color settings as those proposed by Griswold et al. in 2018. A Delphi process, polling the opinion of a panel of 81 experts, was used to generate consensus on the suitability of these maps. Results: Consensus was reached on the suitability of the logarithm-processed Lipari color-map for T1 and the logarithm-processed Navia color-map for T2. There was consensus on color bars being mandatory and on the use of a specific value indicating invalidity. There was no consensus on whether the ranges should be fixed per anatomy. Conclusion: The authors recommend the use of the logarithm-processed Lipari color map for displaying quantitative T1 maps and R1 maps; likewise, the authors recommend the logarithm-processed Navia color-map for displaying T2, T2*, R2 and R2* maps., Comment: 22 pages; embedded are 5 figures and 5 tables; contact the first author for supplementary material. Submitted to Magnetic Resonance in Medicine

Published
2024

2. METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII

Author

Kocak, Burak, Akinci D’Antonoli, Tugba, Mercaldo, Nathaniel, Alberich-Bayarri, Angel, Baessler, Bettina, Ambrosini, Ilaria, Andreychenko, Anna E., Bakas, Spyridon, Beets-Tan, Regina G. H., Bressem, Keno, Buvat, Irene, Cannella, Roberto, Cappellini, Luca Alessandro, Cavallo, Armando Ugo, Chepelev, Leonid L., Chu, Linda Chi Hang, Demircioglu, Aydin, deSouza, Nandita M., Dietzel, Matthias, Fanni, Salvatore Claudio, Fedorov, Andrey, Fournier, Laure S., Giannini, Valentina, Girometti, Rossano, Groot Lipman, Kevin B. W., Kalarakis, Georgios, Kelly, Brendan S., Klontzas, Michail E., Koh, Dow-Mu, Kotter, Elmar, Lee, Ho Yun, Maas, Mario, Marti-Bonmati, Luis, Müller, Henning, Obuchowski, Nancy, Orlhac, Fanny, Papanikolaou, Nikolaos, Petrash, Ekaterina, Pfaehler, Elisabeth, Pinto dos Santos, Daniel, Ponsiglione, Andrea, Sabater, Sebastià, Sardanelli, Francesco, Seeböck, Philipp, Sijtsema, Nanna M., Stanzione, Arnaldo, Traverso, Alberto, Ugga, Lorenzo, Vallières, Martin, van Dijk, Lisanne V., van Griethuysen, Joost J. M., van Hamersvelt, Robbert W., van Ooijen, Peter, Vernuccio, Federica, Wang, Alan, Williams, Stuart, Witowski, Jan, Zhang, Zhongyi, Zwanenburg, Alex, and Cuocolo, Renato

Published
2024
Full Text
View/download PDF

4. Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups

Author

Pasquier, David, Bidaut, Luc, Oprea-Lager, Daniela Elena, deSouza, Nandita M, Krug, David, Collette, Laurence, Kunz, Wolfgang, Belkacemi, Yazid, Bau, Maria Grazia, Caramella, Caroline, De Geus-Oei, Lioe-Fee, De Caluwé, Alex, Deroose, Christophe, Gheysens, Olivier, Herrmann, Ken, Kindts, Isabelle, Kontos, Michalis, Kümmel, Sherko, Linderholm, Barbro, Lopci, Egesta, Meattini, Icro, Smeets, Ann, Kaidar-Person, Orit, Poortmans, Philip, Tsoutsou, Pelagia, Hajjaji, Nawale, Russell, Nicola, Senkus, Elżbieta, Talbot, Jean-Noël, Umutlu, Lale, Vandecaveye, Vincent, Verhoeff, Joost J C, van Oordt, Willemien Menke-van der Houven, Zacho, Helle D, Cardoso, Fatima, Fournier, Laure, Van Duijnhoven, Frederieke, and Lecouvet, Frédéric E

Published
2023
Full Text
View/download PDF

11. Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTC

Author

deSouza, Nandita M., van der Lugt, Aad, Deroose, Christophe M., Alberich-Bayarri, Angel, Bidaut, Luc, Fournier, Laure, Costaridou, Lena, Oprea-Lager, Daniela E., Kotter, Elmar, Smits, Marion, Mayerhoefer, Marius E., Boellaard, Ronald, Caroli, Anna, de Geus-Oei, Lioe-Fee, Kunz, Wolfgang G., Oei, Edwin H., Lecouvet, Frederic, Franca, Manuela, Loewe, Christian, Lopci, Egesta, Caramella, Caroline, Persson, Anders, Golay, Xavier, Dewey, Marc, O’Connor, James P. B., deGraaf, Pim, Gatidis, Sergios, and Zahlmann, Gudrun

Published
2022
Full Text
View/download PDF

12. Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers

Author

Fournier, Laure, Costaridou, Lena, Bidaut, Luc, Michoux, Nicolas, Lecouvet, Frederic E., de Geus-Oei, Lioe-Fee, Boellaard, Ronald, Oprea-Lager, Daniela E., Obuchowski, Nancy A, Caroli, Anna, Kunz, Wolfgang G., Oei, Edwin H., O’Connor, James P. B., Mayerhoefer, Marius E., Franca, Manuela, Alberich-Bayarri, Angel, Deroose, Christophe M., Loewe, Christian, Manniesing, Rashindra, Caramella, Caroline, Lopci, Egesta, Lassau, Nathalie, Persson, Anders, Achten, Rik, Rosendahl, Karen, Clement, Olivier, Kotter, Elmar, Golay, Xavier, Smits, Marion, Dewey, Marc, Sullivan, Daniel C., van der Lugt, Aad, deSouza, Nandita M., and European Society of Radiology

Published
2021
Full Text
View/download PDF

15. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

Author

Guckenberger, Matthias, Lievens, Yolande, Bouma, Angelique B, Collette, Laurence, Dekker, Andre, deSouza, Nandita M, Dingemans, Anne-Marie C, Fournier, Beatrice, Hurkmans, Coen, Lecouvet, Frédéric E, Meattini, Icro, Méndez Romero, Alejandra, Ricardi, Umberto, Russell, Nicola S, Schanne, Daniel H, Scorsetti, Marta, Tombal, Bertrand, Verellen, Dirk, Verfaillie, Christine, and Ost, Piet

Published
2020
Full Text
View/download PDF

17. Impact of the COVID-19 crisis on imaging in oncological trials

Author

Deroose, Christophe M., Lecouvet, Frédéric E., Collette, Laurence, Oprea-Lager, Daniela E., Kunz, Wolfgang G., Bidaut, Luc, Verhoeff, Joost J. C., Caramella, Caroline, Lopci, Egesta, Tombal, Bertrand, de Geus-Oei, Lioe-Fee, Fournier, Laure, Smits, Marion, and deSouza, Nandita M.

Published
2020
Full Text
View/download PDF

22. Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer

Author

Kocher, Hemant M., Basu, Bristi, Froeling, Fieke E. M., Sarker, Debashis, Slater, Sarah, Carlin, Dominic, deSouza, Nandita M., De Paepe, Katja N., Goulart, Michelle R., Hughes, Christine, Imrali, Ahmet, Roberts, Rhiannon, Pawula, Maria, Houghton, Richard, Lawrence, Cheryl, Yogeswaran, Yathushan, Mousa, Kelly, Coetzee, Carike, Sasieni, Peter, Prendergast, Aaron, and Propper, David J.

Published
2020
Full Text
View/download PDF

24. Supplementary Table 2 from First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies

Author

Yap, Timothy A., primary, Arkenau, Hendrik-Tobias, primary, Camidge, D. Ross, primary, George, Suzanne, primary, Serkova, Natalie J., primary, Gwyther, Stephen J., primary, Spratlin, Jennifer L., primary, Lal, Rohit, primary, Spicer, James, primary, Desouza, Nandita M., primary, Leach, Martin O., primary, Chick, Jon, primary, Poondru, Srinivasu, primary, Boinpally, Ramesh, primary, Gedrich, Richard, primary, Brock, Katie, primary, Stephens, Andrew, primary, Eckhardt, S. Gail, primary, Kaye, Stan B., primary, Demetri, George, primary, and Scurr, Michelle, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figure 3 from First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies

Author

Yap, Timothy A., primary, Arkenau, Hendrik-Tobias, primary, Camidge, D. Ross, primary, George, Suzanne, primary, Serkova, Natalie J., primary, Gwyther, Stephen J., primary, Spratlin, Jennifer L., primary, Lal, Rohit, primary, Spicer, James, primary, Desouza, Nandita M., primary, Leach, Martin O., primary, Chick, Jon, primary, Poondru, Srinivasu, primary, Boinpally, Ramesh, primary, Gedrich, Richard, primary, Brock, Katie, primary, Stephens, Andrew, primary, Eckhardt, S. Gail, primary, Kaye, Stan B., primary, Demetri, George, primary, and Scurr, Michelle, primary

Published
2023
Full Text
View/download PDF

26. Sup Figure 3 from Interrogating Two Schedules of the AKT Inhibitor MK-2206 in Patients with Advanced Solid Tumors Incorporating Novel Pharmacodynamic and Functional Imaging Biomarkers

Author

Yap, Timothy A., primary, Yan, Li, primary, Patnaik, Amita, primary, Tunariu, Nina, primary, Biondo, Andrea, primary, Fearen, Ivy, primary, Papadopoulos, Kyriakos P., primary, Olmos, David, primary, Baird, Richard, primary, Delgado, Liliana, primary, Tetteh, Ernestina, primary, Beckman, Robert A., primary, Lupinacci, Lisa, primary, Riisnaes, Ruth, primary, Decordova, Shaun, primary, Heaton, Simon P., primary, Swales, Karen, primary, deSouza, Nandita M., primary, Leach, Martin O., primary, Garrett, Michelle D., primary, Sullivan, Daniel M., primary, de Bono, Johann S., primary, and Tolcher, Anthony W., primary

Published
2023
Full Text
View/download PDF

27. Sup Figure 4 from Interrogating Two Schedules of the AKT Inhibitor MK-2206 in Patients with Advanced Solid Tumors Incorporating Novel Pharmacodynamic and Functional Imaging Biomarkers

Author

Yap, Timothy A., primary, Yan, Li, primary, Patnaik, Amita, primary, Tunariu, Nina, primary, Biondo, Andrea, primary, Fearen, Ivy, primary, Papadopoulos, Kyriakos P., primary, Olmos, David, primary, Baird, Richard, primary, Delgado, Liliana, primary, Tetteh, Ernestina, primary, Beckman, Robert A., primary, Lupinacci, Lisa, primary, Riisnaes, Ruth, primary, Decordova, Shaun, primary, Heaton, Simon P., primary, Swales, Karen, primary, deSouza, Nandita M., primary, Leach, Martin O., primary, Garrett, Michelle D., primary, Sullivan, Daniel M., primary, de Bono, Johann S., primary, and Tolcher, Anthony W., primary

Published
2023
Full Text
View/download PDF

28. Sup Figure 1 from Interrogating Two Schedules of the AKT Inhibitor MK-2206 in Patients with Advanced Solid Tumors Incorporating Novel Pharmacodynamic and Functional Imaging Biomarkers

Author

Yap, Timothy A., primary, Yan, Li, primary, Patnaik, Amita, primary, Tunariu, Nina, primary, Biondo, Andrea, primary, Fearen, Ivy, primary, Papadopoulos, Kyriakos P., primary, Olmos, David, primary, Baird, Richard, primary, Delgado, Liliana, primary, Tetteh, Ernestina, primary, Beckman, Robert A., primary, Lupinacci, Lisa, primary, Riisnaes, Ruth, primary, Decordova, Shaun, primary, Heaton, Simon P., primary, Swales, Karen, primary, deSouza, Nandita M., primary, Leach, Martin O., primary, Garrett, Michelle D., primary, Sullivan, Daniel M., primary, de Bono, Johann S., primary, and Tolcher, Anthony W., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure 1 from First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies

Author

Yap, Timothy A., primary, Arkenau, Hendrik-Tobias, primary, Camidge, D. Ross, primary, George, Suzanne, primary, Serkova, Natalie J., primary, Gwyther, Stephen J., primary, Spratlin, Jennifer L., primary, Lal, Rohit, primary, Spicer, James, primary, Desouza, Nandita M., primary, Leach, Martin O., primary, Chick, Jon, primary, Poondru, Srinivasu, primary, Boinpally, Ramesh, primary, Gedrich, Richard, primary, Brock, Katie, primary, Stephens, Andrew, primary, Eckhardt, S. Gail, primary, Kaye, Stan B., primary, Demetri, George, primary, and Scurr, Michelle, primary

Published
2023
Full Text
View/download PDF

30. Supplementary Methods from First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies

Author

Yap, Timothy A., primary, Arkenau, Hendrik-Tobias, primary, Camidge, D. Ross, primary, George, Suzanne, primary, Serkova, Natalie J., primary, Gwyther, Stephen J., primary, Spratlin, Jennifer L., primary, Lal, Rohit, primary, Spicer, James, primary, Desouza, Nandita M., primary, Leach, Martin O., primary, Chick, Jon, primary, Poondru, Srinivasu, primary, Boinpally, Ramesh, primary, Gedrich, Richard, primary, Brock, Katie, primary, Stephens, Andrew, primary, Eckhardt, S. Gail, primary, Kaye, Stan B., primary, Demetri, George, primary, and Scurr, Michelle, primary

Published
2023
Full Text
View/download PDF

31. Supplementary Table 1 from First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies

Author

Yap, Timothy A., primary, Arkenau, Hendrik-Tobias, primary, Camidge, D. Ross, primary, George, Suzanne, primary, Serkova, Natalie J., primary, Gwyther, Stephen J., primary, Spratlin, Jennifer L., primary, Lal, Rohit, primary, Spicer, James, primary, Desouza, Nandita M., primary, Leach, Martin O., primary, Chick, Jon, primary, Poondru, Srinivasu, primary, Boinpally, Ramesh, primary, Gedrich, Richard, primary, Brock, Katie, primary, Stephens, Andrew, primary, Eckhardt, S. Gail, primary, Kaye, Stan B., primary, Demetri, George, primary, and Scurr, Michelle, primary

Published
2023
Full Text
View/download PDF

32. Sup Figure 2 from Interrogating Two Schedules of the AKT Inhibitor MK-2206 in Patients with Advanced Solid Tumors Incorporating Novel Pharmacodynamic and Functional Imaging Biomarkers

Author

Yap, Timothy A., primary, Yan, Li, primary, Patnaik, Amita, primary, Tunariu, Nina, primary, Biondo, Andrea, primary, Fearen, Ivy, primary, Papadopoulos, Kyriakos P., primary, Olmos, David, primary, Baird, Richard, primary, Delgado, Liliana, primary, Tetteh, Ernestina, primary, Beckman, Robert A., primary, Lupinacci, Lisa, primary, Riisnaes, Ruth, primary, Decordova, Shaun, primary, Heaton, Simon P., primary, Swales, Karen, primary, deSouza, Nandita M., primary, Leach, Martin O., primary, Garrett, Michelle D., primary, Sullivan, Daniel M., primary, de Bono, Johann S., primary, and Tolcher, Anthony W., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure 2 from First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies

Author

Yap, Timothy A., primary, Arkenau, Hendrik-Tobias, primary, Camidge, D. Ross, primary, George, Suzanne, primary, Serkova, Natalie J., primary, Gwyther, Stephen J., primary, Spratlin, Jennifer L., primary, Lal, Rohit, primary, Spicer, James, primary, Desouza, Nandita M., primary, Leach, Martin O., primary, Chick, Jon, primary, Poondru, Srinivasu, primary, Boinpally, Ramesh, primary, Gedrich, Richard, primary, Brock, Katie, primary, Stephens, Andrew, primary, Eckhardt, S. Gail, primary, Kaye, Stan B., primary, Demetri, George, primary, and Scurr, Michelle, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Figure Legend from First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies

Author

Yap, Timothy A., primary, Arkenau, Hendrik-Tobias, primary, Camidge, D. Ross, primary, George, Suzanne, primary, Serkova, Natalie J., primary, Gwyther, Stephen J., primary, Spratlin, Jennifer L., primary, Lal, Rohit, primary, Spicer, James, primary, Desouza, Nandita M., primary, Leach, Martin O., primary, Chick, Jon, primary, Poondru, Srinivasu, primary, Boinpally, Ramesh, primary, Gedrich, Richard, primary, Brock, Katie, primary, Stephens, Andrew, primary, Eckhardt, S. Gail, primary, Kaye, Stan B., primary, Demetri, George, primary, and Scurr, Michelle, primary

Published
2023
Full Text
View/download PDF

35. Supplementary Data from Interrogating Two Schedules of the AKT Inhibitor MK-2206 in Patients with Advanced Solid Tumors Incorporating Novel Pharmacodynamic and Functional Imaging Biomarkers

Author

Yap, Timothy A., primary, Yan, Li, primary, Patnaik, Amita, primary, Tunariu, Nina, primary, Biondo, Andrea, primary, Fearen, Ivy, primary, Papadopoulos, Kyriakos P., primary, Olmos, David, primary, Baird, Richard, primary, Delgado, Liliana, primary, Tetteh, Ernestina, primary, Beckman, Robert A., primary, Lupinacci, Lisa, primary, Riisnaes, Ruth, primary, Decordova, Shaun, primary, Heaton, Simon P., primary, Swales, Karen, primary, deSouza, Nandita M., primary, Leach, Martin O., primary, Garrett, Michelle D., primary, Sullivan, Daniel M., primary, de Bono, Johann S., primary, and Tolcher, Anthony W., primary

Published
2023
Full Text
View/download PDF

36. Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups

Author

Pasquier, David (author), Bidaut, Luc (author), Oprea-Lager, Daniela Elena (author), deSouza, Nandita M. (author), Krug, David (author), Collette, Laurence (author), Kunz, Wolfgang (author), Belkacemi, Yazid (author), de Geus-Oei, L.F. (author), Pasquier, David (author), Bidaut, Luc (author), Oprea-Lager, Daniela Elena (author), deSouza, Nandita M. (author), Krug, David (author), Collette, Laurence (author), Kunz, Wolfgang (author), Belkacemi, Yazid (author), and de Geus-Oei, L.F. (author)

Abstract

Breast cancer remains the most common cause of cancer death among women. Despite its considerable histological and molecular heterogeneity, those characteristics are not distinguished in most definitions of oligometastatic disease and clinical trials of oligometastatic breast cancer. After an exhaustive review of the literature covering all aspects of oligometastatic breast cancer, 35 experts from the European Organisation for Research and Treatment of Cancer Imaging and Breast Cancer Groups elaborated a Delphi questionnaire aimed at offering consensus recommendations, including oligometastatic breast cancer definition, optimal diagnostic pathways, and clinical trials required to evaluate the effect of diagnostic imaging strategies and metastasis-directed therapies. The main recommendations are the introduction of modern imaging methods in metastatic screening for an earlier diagnosis of oligometastatic breast cancer and the development of prospective trials also considering the histological and molecular complexity of breast cancer. Strategies for the randomisation of imaging methods and therapeutic approaches in different subsets of patients are also addressed., Green Open Access added to TU Delft Institutional Repository ‘You share, we take care!’ – Taverne project https://www.openaccess.nl/en/you-share-we-take-care Otherwise as indicated in the copyright section: the publisher is the copyright holder of this work and the author uses the Dutch legislation to make this work public., RST/Radiation, Science and Technology

Published
2023
Full Text
View/download PDF

37. Delivering a Quantitative Imaging Agenda

Author

deSouza, Nandita M., van der Lugt, Aad, Hall, Timothy J., Sullivan, Daniel, Zahlmann, Gudrun, deSouza, Nandita M., van der Lugt, Aad, Hall, Timothy J., Sullivan, Daniel, and Zahlmann, Gudrun

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results